MHLW Recommends Permanent New Drug Price Reforms For 2014
This article was originally published in PharmAsia News
Executive Summary
Japan’s MHLW proposed to the Central Social Insurance Medical Council’s Special Committee on Drug Prices on Nov. 27 that the premium to promote the development of new drugs and eliminate off-label use, in a trial phase in Japan since 2010, be institutionalized in the country’s drug price system reforms for 2014.